Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve.

Alzheimer's disease brain maintenance brain reserve cognitive reserve mid-life cognitive demands occupation

Journal

Frontiers in psychology
ISSN: 1664-1078
Titre abrégé: Front Psychol
Pays: Switzerland
ID NLM: 101550902

Informations de publication

Date de publication:
2022
Historique:
received: 30 05 2022
accepted: 07 11 2022
entrez: 26 12 2022
pubmed: 27 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Several lifestyle factors promote protection against Alzheimer's disease (AD) throughout a person's lifespan. Although such protective effects have been described for occupational cognitive requirements (OCR) in midlife, it is currently unknown whether they are conveyed by brain maintenance (BM), brain reserve (BR), or cognitive reserve (CR) or a combination of them. We systematically derived hypotheses for these resilience concepts and tested them in the population-based AgeCoDe cohort and memory clinic-based AD high-risk DELCODE study. The OCR score (OCRS) was measured using job activities based on the O*NET occupational classification system. Four sets of analyses were conducted: (1) the interaction of OCR and APOE-ε4 with regard to cognitive decline (N = 2,369, AgeCoDe), (2) association with differentially shaped retrospective trajectories before the onset of dementia of the Alzheimer's type (DAT; N = 474, AgeCoDe), (3) cross-sectional interaction of the OCR and cerebrospinal fluid (CSF) AD biomarkers and brain structural measures regarding memory function (N = 873, DELCODE), and (4) cross-sectional and longitudinal association of OCR with CSF AD biomarkers and brain structural measures (N = 873, DELCODE). Regarding (1), higher OCRS was associated with a reduced association of APOE-ε4 with cognitive decline (mean follow-up = 6.03 years), consistent with CR and BR. Regarding (2), high OCRS was associated with a later onset but subsequently stronger cognitive decline in individuals converting to DAT, consistent with CR. Regarding (3), higher OCRS was associated with a weaker association of the CSF Aβ42/40 ratio and hippocampal volume with memory function, consistent with CR. Regarding (4), OCR was not associated with the levels or changes in CSF AD biomarkers (mean follow-up = 2.61 years). We found a cross-sectional, age-independent association of OCRS with some MRI markers, but no association with 1-year-change. OCR was not associated with the intracranial volume. These results are not completely consistent with those of BR or BM. Our results support the link between OCR and CR. Promoting and seeking complex and stimulating work conditions in midlife could therefore contribute to increased resistance to pathologies in old age and might complement prevention measures aimed at reducing pathology.

Identifiants

pubmed: 36571008
doi: 10.3389/fpsyg.2022.957308
pmc: PMC9773841
doi:

Types de publication

Journal Article

Langues

eng

Pagination

957308

Informations de copyright

Copyright © 2022 Kleineidam, Wolfsgruber, Weyrauch, Zulka, Forstmeier, Roeske, van den Bussche, Kaduszkiewicz, Wiese, Weyerer, Werle, Fuchs, Pentzek, Brettschneider, König, Weeg, Bickel, Luppa, Rodriguez, Freiesleben, Erdogan, Unterfeld, Peters, Spruth, Altenstein, Lohse, Priller, Fliessbach, Kobeleva, Schneider, Bartels, Schott, Wiltfang, Maier, Glanz, Incesoy, Butryn, Düzel, Buerger, Janowitz, Ewers, Rauchmann, Perneczky, Kilimann, Görß, Teipel, Laske, Munk, Spottke, Roy, Brosseron, Heneka, Ramirez, Yakupov, Scherer, Maier, Jessen, Riedel-Heller and Wagner.

Déclaration de conflit d'intérêts

ME receives research funding and consulting fees from Eli Lilly and Company. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Biometrics. 2006 Dec;62(4):1025-36
pubmed: 17156276
J Alzheimers Dis. 2018;64(s1):S199-S211
pubmed: 29504542
Ann Neurol. 1988 Feb;23(2):138-44
pubmed: 2897823
Neuroimage. 2012 Jul 16;61(4):1402-18
pubmed: 22430496
Dement Geriatr Cogn Disord. 2007;24(4):307-16
pubmed: 17848793
Trends Cogn Sci. 2012 May;16(5):292-305
pubmed: 22542563
Brain. 2011 May;134(Pt 5):1479-92
pubmed: 21478184
Neurology. 2003 Mar 11;60(5):831-6
pubmed: 12629242
Alzheimers Res Ther. 2018 Feb 07;10(1):15
pubmed: 29415768
Arch Gen Psychiatry. 2010 Apr;67(4):414-22
pubmed: 20368517
Alzheimers Dement. 2017 Apr;13(4):431-440
pubmed: 27693184
J Health Econ. 2017 Dec;56:113-125
pubmed: 29040897
Neuropsychology. 2018 Nov;32(8):895-905
pubmed: 29985017
Lancet Neurol. 2012 Nov;11(11):1006-12
pubmed: 23079557
Clin Geriatr Med. 2020 May;36(2):247-263
pubmed: 32222300
Brain. 2014 Apr;137(Pt 4):1167-75
pubmed: 24578544
Brain. 2010 Aug;133(Pt 8):2210-6
pubmed: 20826429
BMJ. 1997 Jan 4;314(7073):34-5
pubmed: 9001477
J Alzheimers Dis Parkinsonism. 2017;7(6):
pubmed: 29423338
Psychol Aging. 2018 Mar;33(2):195-218
pubmed: 29658744
Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S13-21
pubmed: 9236948
J Alzheimers Dis. 2019;70(2):361-370
pubmed: 31256140
Ann Intern Med. 2018 Jan 2;168(1):63-68
pubmed: 29255842
J Alzheimers Dis. 2016 Nov 1;55(1):283-292
pubmed: 27662289
Neuroimage. 2015 Jul 15;115:117-37
pubmed: 25936807
Arch Clin Neuropsychol. 2015 Nov;30(7):634-42
pubmed: 26156334
Neurology. 1995 Jan;45(1):55-60
pubmed: 7824135
Am J Epidemiol. 2008 Apr 1;167(7):820-30
pubmed: 18263600
Arch Gen Psychiatry. 1983 Jul;40(7):812
pubmed: 6860082
Front Hum Neurosci. 2019 Dec 20;13:449
pubmed: 31920603
Neurology. 2014 Dec 9;83(24):2285-91
pubmed: 25411439
Int J Geriatr Psychiatry. 2021 Jan;36(1):152-162
pubmed: 32819031
Curr Opin Psychiatry. 2020 Mar;33(2):178-184
pubmed: 31789678
Psychol Aging. 2012 Jun;27(2):353-63
pubmed: 21875213
J Neurol Neurosurg Psychiatry. 1995 May;58(5):590-7
pubmed: 7745409
Neurology. 2019 Feb 19;92(8):e831-e840
pubmed: 30674595
Neurology. 2016 Apr 12;86(15):1386-1392
pubmed: 26984944
Psychol Med. 1991 Feb;21(1):225-36
pubmed: 2047500
PLoS One. 2012;7(6):e38268
pubmed: 22675535
PLoS One. 2014 Mar 13;9(3):e91196
pubmed: 24625888
J Alzheimers Dis. 2017;56(3):1185-1196
pubmed: 28106560
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Neuropsychology. 2012 Jul;26(4):459-72
pubmed: 22642392
Neuroepidemiology. 2014;43(1):15-25
pubmed: 25248074
Cereb Cortex. 2004 Jan;14(1):11-22
pubmed: 14654453
J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9
pubmed: 22002422
J Alzheimers Dis. 2019;70(2):553-562
pubmed: 31256117
Am J Psychiatry. 1982 Sep;139(9):1136-9
pubmed: 7114305
Mol Psychiatry. 2011 Sep;16(9):903-7
pubmed: 21556001
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
Neurology. 2009 Aug 4;73(5):356-61
pubmed: 19652139
Front Aging Neurosci. 2015 Aug 10;7:134
pubmed: 26321944
Neurology. 2008 Oct 21;71(17):1342-9
pubmed: 18936426
Neuropsychologia. 2013 May;51(6):1124-31
pubmed: 23499725
J Gerontol B Psychol Sci Soc Sci. 2016 Sep;71(5):849-56
pubmed: 25975289
Neurology. 2019 Mar 5;92(10):e1041-e1050
pubmed: 30728309
Am J Epidemiol. 2011 Nov 1;174(9):1077-88
pubmed: 21965187
J Gerontol B Psychol Sci Soc Sci. 2015 Mar;70(2):314-21
pubmed: 25190210
Ageing Res Rev. 2020 Mar;58:101002
pubmed: 31899366
J Neurosci. 2013 May 8;33(19):8237-42
pubmed: 23658162
J Gerontol A Biol Sci Med Sci. 2020 Sep 25;75(10):1820-1826
pubmed: 31639181
Neurobiol Aging. 2005 Jan;26(1):17-24
pubmed: 15585342
J Gerontol B Psychol Sci Soc Sci. 2005 Mar;60(2):P74-83
pubmed: 15746021
Nat Rev Neurosci. 2018 Nov;19(11):701-710
pubmed: 30305711
Ann Neurol. 1980 May;7(5):486-8
pubmed: 7396427
J Gerontol B Psychol Sci Soc Sci. 2019 Sep 15;74(7):1189-1199
pubmed: 28958077
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Neuroimage. 2012 Nov 15;63(3):1542-51
pubmed: 22902920
Neurology. 2007 Oct 23;69(17):1657-64
pubmed: 17954781
Alzheimers Dement. 2020 Sep;16(9):1305-1311
pubmed: 30222945
Front Aging Neurosci. 2021 Jan 13;12:622321
pubmed: 33536897
Neurobiol Aging. 2019 Dec;84:109-118
pubmed: 31539647
Neurology. 2020 Sep 1;95(9):e1134-e1143
pubmed: 32636322

Auteurs

Luca Kleineidam (L)

Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Steffen Wolfsgruber (S)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Anne-Sophie Weyrauch (AS)

Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.

Linn E Zulka (LE)

Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
Department of Psychology and Centre for Ageing and Health (AgeCap), University of Gothenburg, Gothenburg, Sweden.

Simon Forstmeier (S)

Developmental Psychology and Clinical Psychology of the Lifespan, University of Siegen, Siegen, Germany.

Sandra Roeske (S)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Hendrik van den Bussche (H)

Department of Primary Medical Care, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Hanna Kaduszkiewicz (H)

Department of Primary Medical Care, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Medical Faculty, Institute of General Practice, University of Kiel, Kiel, Germany.

Birgitt Wiese (B)

Center for Information Management, Hannover Medical School, Hanover, Germany.

Siegfried Weyerer (S)

Medical Faculty, Central Institute of Mental Health, Mannheim/Heidelberg University, Heidelberg, Germany.

Jochen Werle (J)

Medical Faculty, Central Institute of Mental Health, Mannheim/Heidelberg University, Heidelberg, Germany.

Angela Fuchs (A)

Medical Faculty, Centre for Health and Society (CHS), Institute of General Practice (ifam), Heinrich Heine University, Düsseldorf, Germany.

Michael Pentzek (M)

Medical Faculty, Centre for Health and Society (CHS), Institute of General Practice (ifam), Heinrich Heine University, Düsseldorf, Germany.

Christian Brettschneider (C)

Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Hans-Helmut König (HH)

Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Dagmar Weeg (D)

Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany.

Horst Bickel (H)

Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany.

Melanie Luppa (M)

Medical Faculty, Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Francisca S Rodriguez (FS)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Medical Faculty, Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Silka Dawn Freiesleben (SD)

German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Department of Psychiatry, Campus Berlin-Buch, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Berlin, Germany.
Memory Clinic and Dementia Prevention Center, Experimental and Clinical Research Center (ECRC), Berlin, Germany.

Selin Erdogan (S)

German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Department of Psychiatry, Campus Berlin-Buch, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Berlin, Germany.
Memory Clinic and Dementia Prevention Center, Experimental and Clinical Research Center (ECRC), Berlin, Germany.

Chantal Unterfeld (C)

German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Department of Psychiatry, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Berlin, Germany.

Oliver Peters (O)

German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Department of Psychiatry, Campus Berlin-Buch, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Berlin, Germany.
Memory Clinic and Dementia Prevention Center, Experimental and Clinical Research Center (ECRC), Berlin, Germany.

Eike J Spruth (EJ)

German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Slawek Altenstein (S)

German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Andrea Lohse (A)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Josef Priller (J)

Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
University of Edinburgh and UK DRI, Edinburgh, United Kingdom.

Klaus Fliessbach (K)

Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Xenia Kobeleva (X)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Anja Schneider (A)

Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Claudia Bartels (C)

Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany.

Björn H Schott (BH)

Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany.
German Center for Neurodegenerative Diseases (DZNE), Goettingen, Germany.
Leibniz Institute for Neurobiology, Magdeburg, Germany.

Jens Wiltfang (J)

Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany.
German Center for Neurodegenerative Diseases (DZNE), Goettingen, Germany.
Department of Medical Sciences, Neurosciences and Signaling Group, Institute of Biomedicine (iBiMED), University of Aveiro, Aveiro, Portugal.

Franziska Maier (F)

Department of Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany.

Wenzel Glanz (W)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.

Enise I Incesoy (EI)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Institute of Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University, Magdeburg, Germany.

Michaela Butryn (M)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.

Emrah Düzel (E)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Institute of Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University, Magdeburg, Germany.

Katharina Buerger (K)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.

Daniel Janowitz (D)

Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.

Michael Ewers (M)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.

Boris-Stephan Rauchmann (BS)

Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.

Robert Perneczky (R)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Ageing Epidemiology Research Unit (AGE), School of Public Health, Imperial College London, London, United Kingdom.
Sheeld Institute for Translational Neuroscience (SITraN), University of Sheeld, Sheeld, United Kingdom.

Ingo Kilimann (I)

German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.
Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany.

Doreen Görß (D)

Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany.

Stefan Teipel (S)

German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.
Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany.

Christoph Laske (C)

German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.

Matthias H J Munk (MHJ)

German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Department of Biology, Technische Universität Darmstadt, Darmstadt, Germany.

Annika Spottke (A)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Department of Neurology, University of Bonn, Bonn, Germany.

Nina Roy (N)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Frederic Brosseron (F)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Michael T Heneka (MT)

Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Alfredo Ramirez (A)

Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.
Department of Psychiatry and Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, San Antonio, TX, United States.

Renat Yakupov (R)

German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.

Martin Scherer (M)

Department of Primary Medical Care, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Wolfgang Maier (W)

Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.

Frank Jessen (F)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Department of Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany.
Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Steffi G Riedel-Heller (SG)

Medical Faculty, Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Michael Wagner (M)

Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Classifications MeSH